Unusual case of drug-induced cholestasis due to glucosamine and chondroitin sulfate

被引:0
|
作者
Stephen Ip [1 ]
Rachel Jeong [2 ]
David F Schaeffer [3 ]
Eric M Yoshida [1 ]
机构
[1] Division of Gastroenterology,Vancouver General Hospital,University of British Columbia
[2] Faculty of Medicine and Dentistry,University of Alberta
[3] Department of Pathology and Laboratory Medicine,University of British Columbia
关键词
Glucosamine; Chondroitin; Hepatotoxicity; Cholestasis; Jaundice;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
Glucosamine(GS) and chondroitin sulfate(CS) are common over-the-counter(OTC) supplements used in the treatment of osteoarthritis. These medications are seemingly safe, but there are increasing reports of hepatotoxicity with these supplements. We reported a unique case of drug-induced cholestasis caused by GS and CS in a combination tablet. The etiology of the jaundice was overlooked despite extensive investigations over a three-month period. Unlike drug-induced hepatocellular injury, drug-induced cholestatic jaundice with GS and CS has only been reported twice before. This case emphasizes the importance of a complete medication history, especially OTC supplements, in the assessment of cholestasis.
引用
收藏
页码:2559 / 2562
页数:4
相关论文
共 50 条
  • [1] Unusual case of drug-induced cholestasis due to glucosamine and chondroitin sulfate
    Ip, Stephen
    Jeong, Rachel
    Schaeffer, David F.
    Yoshida, Eric M.
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (24) : 2559 - 2562
  • [2] Drug-Induced Cholestasis
    Bhamidimarri, Kalyan Ram
    Schiff, Eugene
    CLINICS IN LIVER DISEASE, 2013, 17 (04) : 519 - +
  • [3] Drug-induced hepatitis with severe cholestasis due to voglibose
    Masumoto, T
    Ishikawa, M
    Yamauchi, Y
    Hiasa, Y
    Yamamoto, K
    Iuchi, H
    Ohkubo, K
    Akbar, SMF
    Michitaka, K
    Horiike, N
    Onji, M
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1996, 5 (4-5): : 289 - 296
  • [4] Drug-Induced Cholestasis
    Bjornsson, Einar S.
    Jonasson, Jon Gunnlaugur
    CLINICS IN LIVER DISEASE, 2013, 17 (02) : 191 - +
  • [5] Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy
    Pauli-Magnus, Christiane
    Meier, Peter J.
    Stieger, Bruno
    SEMINARS IN LIVER DISEASE, 2010, 30 (02) : 147 - 159
  • [6] Drug-induced hepatic cholestasis in the critically ill
    Frenette, Anne Julie
    Dufresne, Marie-Eve Bedard
    Bonhomme, Valerie
    Albert, Martin
    Williamson, David R.
    INTENSIVE CARE MEDICINE, 2011, 37 (07) : 1225 - 1226
  • [7] Predicting drug-induced cholestasis: preclinical models
    Petrov, Petar D.
    Leonor Fernandez-Murga, M.
    Lopez-Riera, Mireia
    Jose Gomez-Lechon, M.
    Castell, Jose V.
    Jover, Ramiro
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (07) : 721 - 738
  • [8] Drug-induced hepatic cholestasis in the critically ill
    Anne Julie Frenette
    Marie-Eve Bédard Dufresne
    Valérie Bonhomme
    Martin Albert
    David R. Williamson
    Intensive Care Medicine, 2011, 37 : 1225 - 1226
  • [9] Drug-induced Cholestasis: Mechanisms, Models, and Markers
    Chatterjee, Sagnik
    Annaert, Pieter
    CURRENT DRUG METABOLISM, 2018, 19 (10) : 808 - 818
  • [10] Drug-induced liver injury due to antibiotics
    Bjornsson, Einar S.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) : 617 - 623